Publications (pdf)

 

Peer-reviewed Publications

Cools R, Rogers R, Barker RA, Robbins TW (2009). Top-down attentional control in Parkinson’s disease: salient considerations. J Cogn Neurosci In Press

 

Cools R, Frank MF, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2009). Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29: 1538-1543.

 

Clatworthy P, Lewis S, Brichard L, Hong Y, Izquierdo D, Clark L, Cools R, Aigbirhio F, Baron J-C, Fryer T, Robbins TW (2009). Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci In Press

 

Kehagia A.A., Cools R, Barker R.A., Robbins T.W (2009). Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson’s disease. Neuropsychologia  Jan 8. [Epub ahead of print]

Robinson OJ, Cools R, Crockett M, Sahakian BJ. Mood State moderates the role of serotonin in cognitive biases. J Psychopharmacolog. In Press.


Ragland JD, Cools R, Frank M, Pizzagalli DA, Preston A, Ranganath C, Wagner AD. CNTRICS Final Task Selection: Long-term Memory. Schiz Bull. In Press.


Murray GK, Clark L, Corlett PR, Blackwell AD, Cools R, Jones PB, Robbins TW, Poustka L (2008). Incentive Motivation Processing in First-Episode Psychosis: a Behavioural Study. BMC Psychiatry 8:34.

Dodds M, Müller U, Clark L, van Loon A, Cools R & Robbins TW (2008). Methylphenidate has differential effects on BOLD signal related to cognitive sub-processes of reversal learning. J Neurosci 28 (23):5976-82.


Cools R (2008). Role of dopamine in the motivational and cognitive control of behaviour. Neuroscientist 14 (4):381-95.


Cools R, Gibbs SE, Miyakawa A, Jagust WE, D’Esposito M (2008). Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28 (5):1208-12


Cools R, Roberts AC, Robbins TW (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12 (1):31-40.


Cools R, Robinson OJ, Sahakian BJ (2008). Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology 33(9):2291-9.


Cools R, Sheridan M, Jacobs EJ, D’Esposito MD (2007). Impulsive personality predicts dopamine-dependent changes in fronto-striatal activity during component processes of working memory. J Neurosci 27(20): 5506-5514.


Cools R, Lewis SGJ, Clark L, Barker RA, Robbins TW (2007). L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson’s disease. Neuropsychopharmacology 32 (1): 180-189.


Cools R, Ivry RB, D’Esposito M (2006). The human striatum is necessary for responding to changes in stimulus relevance. J Cogn Neurosci 18: 1973-1983


Funkiewiez A, Ardouin C, Cools R, Krack P, Fraix V, Batir A, Chabardès S, Benabid AL, Robbins TW, Pollak P (2006). Effects of levodopa and bilateral STN stimulation on cognitive and affective functioning of cortico-striatal ‘loops’. Mov Disorders 21:1656-1662


Cools R, Altamirano L, D’Esposito M (2006). Reversal learning in Parkinson’s disease depends on medication status and outcome valence. Neuropsychologia 44 (10):1663-1673


Roiser JP, Blackwell AD, Cools R, Clark L, Rubinsztein DC, Robbins TW, Sahakian BJ (2006). Serotonin transporter polymorphism mediates vulnerability to loss of motivated action following acute tryptophan depletion. Neuropsychopharmacology 31 (10):2264-2272


Cools R (2006) Dopaminergic modulation of cognitive function – Implication for L-DOPA therapy in Parkinson’s disease. Neurosci Biobehav Rev 30 (1):1-34.


Cools R, Calder AJ, Lawrence AD, Clark L, Bullmore E, Robbins TW (2005). Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology 180: 670-679.


Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbins TW (2005). Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30 (7): 1362-1373.


Evers EAT, Cools R, Clark L, van der Veen FM, Jolles J, Sahakian BJ, Robbins TW (2005). Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 30 (6): 1138-1147.


Clark L, Roiser JP, Cools R, Rubinsztein DC, Sahakian BJ, Robbins TW (2005). Stop signal response inhibition in not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 182 (2005): 570-578.


Cools R, Robbins TW (2004). Chemistry of the Adaptive Mind. Philos Transact Ser A Math Phys Eng Sci 362 (1825): 2871-2888.


Cools R, Clark L, Robbins TW (2004). Differential responses in human striatum and prefrontal cortex to changes in object- and rule-relevance. J Neurosci 24:1129-35.


Clark L, Cools R, Robbins T W (2004) The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning. Brain Cogn 55:41-53.


Cools R, Barker R A, Sahakian B J, Robbins T W (2003). L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease. Neuropsychologia 41:1431-1441.


Lewis SJG, Cools R, Robbins TW, Dove A, Barker RA, Owen AM (2003). Using executive heterogeneity to explore the nature of working memory deficits in Parkinson’s disease. Neuropsychologia 41: 645-652.


Cools R, Clark L, Owen AM, Robbins TW (2002). Defining the neural mechanisms of probabilistic reversal learning using event-related functional MRI. J Neurosci 22: 4563-4567.


Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: The role of prefrontal cortex revealed by PET. Brain 125: 584-594.


Cools R, Barker RA, Sahakian BJ, and Robbins TW (2001). Mechanisms of cognitive set flexibility in Parkinson’s disease. Brain 124:2503-2512.


Cools R, Barker RA, Sahakian BJ, Robbins TW (2001). Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.
Cereb Cortex 11:1136-1143.


Cools R, Brouwer WH, de Jong R, Slooff C (2000).
Flexibility, inhibition, and planning: frontal dysfunctioning in schizophrenia. Brain Cogn 43:108-12.


De Jong R, Berendsen E, Cools R (1999). Goal neglect and inhibitory limitations: dissociable causes of interference effects in conflict situations. Acta Psychologica 101: 379-94

 

Chapters and reviews


Cools R (2006) Dopaminergic modulation of flexible cognitive control: The role of the striatum. In: The neuroscience of rule-guided behavior. Eds. S. A Bunge, J. D.Wallis.


Cools R (2006) Dopaminergic modulation of cognitive flexibility: The role of the striatum. In: Mental Dysfunction in Parkinson’s disease III. Eds. E. Ch. Wolters, H.W., Berendse and C.J. Stam. Amsterdam: VU University Press.

Robbins TW, Crofts HS, Cools R, Roberts AC (2004) Catecholamines and Cognition: Bridging the Gap Between Animal Studies and the Clinical Syndromes. In: Mental and Behavioral Dysfunction in Movement Disorders. Eds E-A Bedard et al. Humana Press Inc., Totowa, NJ: 183-200.


Cools R and Roberts A. C (2004). The role of dopamine in cognition: Insights from neuropsychological studies in humans and non-human primates. In: Prefrontal Cortex: from Synapse to Cognition. Ed. S. Otani: 219-243.


Cools R, Swainson R, Owen AM, Robbins TW (1999). Cognitive Dysfunction in non-demented Parkinson’s disease. In: Mental Dysfunction in Parkinson’s disease. Eds. E.Ch. Wolters, Ph Scheltens, M W Berendse. Utrecht: Academic Pharmaceutical Productions bv.